Analogic (ALOG) Downgraded by BidaskClub to “Sell”
Analogic (NASDAQ:ALOG) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday.
Other research analysts have also recently issued research reports about the company. Jefferies Group began coverage on Analogic in a research note on Wednesday, August 9th. They issued a “hold” rating and a $75.00 price target on the stock. Zacks Investment Research lowered Analogic from a “buy” rating to a “hold” rating in a report on Tuesday, November 21st. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $85.25.
Analogic (ALOG) opened at $80.65 on Thursday. The company has a market capitalization of $1,018.75, a PE ratio of 48.57, a price-to-earnings-growth ratio of 4.16 and a beta of 0.86. Analogic has a one year low of $66.00 and a one year high of $87.60.
Large investors have recently bought and sold shares of the company. Flinton Capital Management LLC boosted its position in shares of Analogic by 100.0% during the second quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock worth $129,000 after buying an additional 884 shares during the period. State Board of Administration of Florida Retirement System acquired a new position in shares of Analogic during the third quarter worth approximately $224,000. Piedmont Investment Advisors LLC acquired a new position in shares of Analogic during the third quarter worth approximately $227,000. Crossmark Global Holdings Inc. acquired a new position in shares of Analogic during the third quarter worth approximately $250,000. Finally, Oppenheimer & Co. Inc. acquired a new position in shares of Analogic during the second quarter worth approximately $263,000. 97.61% of the stock is owned by institutional investors.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.